US Sandoz Arm Fights US Overpay Lawsuit

18.06.2015 - Sandoz, Inc., the US arm of Novartis’ generic drugs division, is asking the Supreme Court of the US state of Mississippi to reverse a county court’s $38.2 million judgment against...